From Relapse to Remission: CD38-Targeting Therapies Lead the Way
From Relapse to Remission: CD38-Targeting Therapies Lead the Way CD38-Directed Therapies: Transforming Multiple Myeloma Treatment Multiple Myeloma, a type of blood cancer originating in plasma cells within the bone marrow, continues to pose significant challenges in oncology. However, advancements in treatment have led to the emergence of CD38-di